The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy
NCT ID: NCT01241838
Last Updated: 2012-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
11 participants
INTERVENTIONAL
2011-02-28
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal left ventricular size
Postoperative patient with normal left ventricular size
Pacemaker
Routine postoperative temporary pacemaker Rate change of 65-80-95-110-125 beats/second in random order at day 3-4 after operation
Left ventricular hypertrophy
Postoperative patient with left ventricular hypertrophy
Pacemaker
Routine postoperative temporary pacemaker Rate change of 65-80-95-110-125 beats/second in random order at day 3-4 after operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacemaker
Routine postoperative temporary pacemaker Rate change of 65-80-95-110-125 beats/second in random order at day 3-4 after operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ejection fraction \> 45%
* Duration of QRS complex \< 120 milliseconds
* Sinus rhythm
* Planned perioperative temporary pacemaker
Group: Left ventricular hypertrophy:
Thickness of interventricular septum and posterior wall \>11 mm.
Group: No left ventricular hypertrophy:
Thickness of interventricular septum and posterior wall \<11 mm.
Exclusion Criteria
* Severe mitral insufficiency
* No patient consent
30 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Juhl-Olsen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesiology, Århus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anaesthesiology, Århus University Hospital
Århus N, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1717
Identifier Type: -
Identifier Source: org_study_id